Lost password ?
<< Back to Equity Research
UNIMED
UNIMED OFFERS AN APPEALING POTENTIAL
May 27 - The Tunisian market seems muted about Unimed (Buy, Tunisia) during the last months. The company’s performance was strong with a double digit growth in Q1 2024, although, the share price shows a ...
Executive summary
Conflict of Interest
Pages 34
Language English
Publish on May 27, 2024
€ 500
VAT Exl.
You might be also interested by these reports :
Jul 26 AM
SIPHAT
Another quarter in the red
Jul 23 AM
UNIMED
Exports' deterioration in Q2
Jul 23 AM
UNIMED
The drop in exports in Q2 reduced the upside
Jun 28 AM
UNIMED
An organic profit better than expected in 2023.
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ